Clinical Trials List
Protocol NumberMK-6482-043
Not yet recruiting
2026-03-01 - 2040-12-31
Phase III
Not yet recruiting1
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Yen-Hwa Chang Division of Urology
- Tzu-Hao Huang Division of Urology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
43 participants
